project id: TCGA-ACC; case submitter id: TCGA-OR-A5KU; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.99; rna integrity number: 7.2; age at index: 37; days to birth: -13559; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1963; age at diagnosis: 13559; ajcc clinical m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 4673.0; icd 10 code: C74.0; last known disease status: not reported; morphology: 8370/1; primary diagnosis: Adrenal cortical carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cortex of adrenal gland; synchronous malignancy: No; tissue or organ of origin: Cortex of adrenal gland; tumor grade: Not Reported; year of diagnosis: 2000; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 4543; initial weight: 70.0; sample id: efbcd3a5-723a-4361-9769-c01336f5f22d; sample submitter id: TCGA-OR-A5KU-01A; portion id: 7ab15775-5295-476f-85a1-e0ddd2ac311f; portion submitter id: TCGA-OR-A5KU-01A-11; slide id: 61b510dd-cc21-40d7-b7e6-216ca7767d4d; slide submitter id: TCGA-OR-A5KU-01A-01-TS1; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 15.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 80.0; percent tumor nuclei: 100.0; section location: TOP;